Study of an HIV Preventive Vaccine Given With or Without an Adjuvant in HIV Uninfected Adults
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Scott Parker, MD
University of Alabama at Birmingham
Study Chair - Spyros Kalams, MD
Vanderbilt University
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Chiang Mai Univ. Hvtn Crs
Chiang Mai, Thailand
- Alabama Vaccine Crs
Birmingham, Alabama, United States
- Project Brave Hiv Vaccine Crs
Baltimore, Maryland, United States
- Vanderbilt Vaccine Crs
Nashville, Tennessee, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- —
- Primary completion
- —
- Completion
- 31 May 2008
- Last update posted
- 14 Oct 2021
- Registered enrollment
- 144
- Registry id
- NCT00111605
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.